Prevalence, genotype profile and risk factors for multiple human papillomavirus cervical infection in unimmunized female adolescents in Goiânia, Brazil: A community-based study

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Figueiredo Alves, Rosane Ribeiro ^a,c   Turchi, Marília Dalva ^a   Santos, Lyana Elias ^a   De Britto Guimarães, Eleuse Machado ^a   Garcia, Mônica Maria Danda ^a   Seixas, Mirian Socorro Cardoso ^a   Villa, Luisa Lina ^b   Costa, Maria Cecília ^b   Moreira, Marise Amaral Rebouças ^a   De Fátima Da Costa Alves, Maria ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c University of São Paulo ^*  (Brazil)

Author keywords

Adolescents; Cytological abnormalities; Epidemiology; female; Multiple HPV infection; PCR PGMY09 11 line blot hybridization RFLP

Indexed keywords

ADOLESCENT; ARTICLE; BRAZIL; FEMALE; GENETICS; GENOTYPE; HUMAN; MIXED INFECTION; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UTERINE CERVIX DISEASE; VIROLOGY; YOUNG ADULT;

ADOLESCENT; BRAZIL; COINFECTION; FEMALE; GENOTYPE; HUMANS; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; UTERINE CERVICAL DISEASES; YOUNG ADULT;

EID: 84886741642     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-1041     Document Type: Article

References (31)

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munõz N, J Pathol 1999 189 12 19 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482 (Pubitemid 29406813)
2. Epidemiologic classification of human papillomavirus types associated with cervical cancer. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, N Engl J Med 2003 348 518 527 10.1056/NEJMoa021641 12571259 (Pubitemid 36159887)
3. Multiple HPV infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M, JCM 2013 51 1458 1464
4. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD, J Infect Dis 2005 191 182 192 10.1086/426867 15609227 (Pubitemid 40096375)
5. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. Chaturvedi AK, Katki HA, Hildesheim A, Rodriguez AC, Quint W, Schiffman M, Van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R, J Infect Dis 2011 203 910 920 10.1093/infdis/jiq139 21402543
6. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Nielsen A, Kjaer SK, Munk C, Iftner T, Sex Transm Dis 2008 35 276 282 10.1097/OLQ. 0b013e31815ac5c7 18091564 (Pubitemid 351619532)
7. Predictors of cervical coinfection with multiple human papillomavirus types. Rousseau MC, Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL, Cancer Epidemiol Biomarkers Prev 2003 12 1029 1037 14578139 (Pubitemid 37310259)
8. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Chaturvedi AK, Myers L, Hammons AF, Clark RA, Dunlap K, Kissinger PJ, Hagensee ME, Cancer Epidemiol Biomarkers Prev 2005 14 2439 2445 10.1158/1055-9965.EPI-05-0465 16214929 (Pubitemid 41437849)
9. Cervical coinfection with human papillomavirus types as a predictor of a acquisition and persistence of HPV infection. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL, J Infect Dis 2002 184 1508 1517
10. Concurrent and sequential acquisition of different genital human papilamavirus types. Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam ED, Koutsky LA, J Infect Dis 2000 182 1097 1102 10.1086/315805 10979905
11. Association of chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER, Am J Epidemiol 2005 162 668 675 10.1093/aje/kwi262 16120706 (Pubitemid 41437366)
12. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. Moscicki AB, Shiboski S, Broering J, Powel K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller S, Stone J, Hanson E, Palefsky J, J Pediatr 1998 132 277 284 10.1016/S0022-3476(98)70445-7 9506641 (Pubitemid 28125180)
13. Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. Moscicki A-B, Cox JT, J Low Genit Tract Dis 2010 14 73 80 10.1097/LGT.0b013e3181cec411 20043357
14. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Rousseau MC, Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco AE, Sex Transm Dis 2002 30 581 587
15. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL, Cancer Epidemiol Biomarkers Prev 2006 15 1274 1280 10.1158/1055-9965.EPI-06-0129 16835323 (Pubitemid 44125281)
16. Human papillomavirus and the long-term risk of cervical neoplasia. van der Graaf Y, Molijn A, Doornewaard H, Quint W, van Doorn LJ, van den Tweel J, Am J Epidemiol 2002 156 158 164 10.1093/aje/kwf013 12117707 (Pubitemid 34755954)
17. Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study. Campos NG, Rodriguez AC, Castle PE, Herrero R, Hildesheim A, Katki H, Kim JJ, Wacholder S, Morales J, Burk RD, Schiffman M, J Infect Dis 2011 203 823 827 10.1093/infdis/jiq131 21257737
18. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S, J Infect Dis 2010 202 1789 1799 10.1086/657321 21067372
19. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX, Lancet Infect Dis 2007 7 453 459 10.1016/S1473-3099(07) 70158-5 17597569 (Pubitemid 46962343)
20. Cervical HPV infection in Brazil: systematic review. Ayres ARG, Silva GA, Rev Saúde Pública 2010 44 963 974
21. Lack of utility of risk score and gynecological examination for screening for sexually transmitted infections in sexually active adolescents. Guimarães BE, Guimarães MD, Vieira M, Bontempo NM, Seixas MS, Garcia MD, Daud L, Côrtes R, Alves M, BMC Med 2009 7 8 14 10.1186/1741-7015-7-8 19284575
22. Bethesda system: terminology for reporting results of cervical cytology. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, The YN, et al. JAMA 2001 2002 287 2114 2119
23. Improved amplification of genital human papillomaviruses. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ, J ClinMicrobiol 2000 38 357 361 (Pubitemid 30043317)
24. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM, J Infect Dis 1994 170 1077 1085 10.1093/infdis/170.5.1077 7963696
25. Classification of papillomaviruses. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, Virology 2004 324 17 27 10.1016/j.virol.2004.03.033 15183049 (Pubitemid 38737395)
26. Prevalence of HPV infection among females in the United States. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE, JAMA 2007 297 813 819 10.1001/jama.297.8.813 17327523 (Pubitemid 46333946)
27. Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain. Johnson AM, Mercer CH, Beddows S, de Silva N, Desai S, Howell-Jones R, Carder C, Sonnenberg P, Fenton KA, Lowndes C, Soldan K, Sex Transm Infect 2012 88 212 217 10.1136/sextrans-2011-050306 22261135
28. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD, Pediatrics 2002 109 1 8 10.1542/peds.109.1.1 11773534 (Pubitemid 34049420)
29. Progesterone and 17beta-estradiol enhance regulatory responses to human papillomavirus type 16 virus-like particles in peripheral blood mononuclear cells from healthy women. Marks MA, Gravitt PE, Burk RD, Studentsov Y, Farzadegan H, Klein SL, Clin Vaccine Immunol 2010 17 609 617 10.1128/CVI.00441-09 20130130
30. Interobserver reproducibility of cervical cytologic and histological interpretations: realistic estimates from the ASCUS-LSIL triage study. Stoler M, Schiffman M, JAMA 2001 285 1500 1505 10.1001/jama.285.11.1500 11255427 (Pubitemid 32221899)
31. Interobserver concordance in the assessment of features used for the diagnosis of cervical atypical squamous cells and squamous intraepithelial lesions (ASC-US, ASC-H, LSIL and HSIL). Bigras G, Wilson J, Russell L, Johnson G, Morel D, Saddik M, Cytopathology 2013 24 44 51 10.1111/j.1365-2303.2011. 00930.x 22007754